Zika clinical updates: implications for pediatrics

Kristina Adachi1, Karin Nielsen-Saines

  • 1Department of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Insights

Pediatricians must stay updated on Zika virus (ZIKV) epidemiology, clinical presentation, and management to effectively care for infants and children. Comprehensive knowledge is crucial, especially with evolving screening guidelines for pregnant women.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Zika virus (ZIKV), a mosquito-borne flavivirus, is a significant cause of congenital infections.
  • Understanding ZIKV's impact on pediatric populations is critical for healthcare providers.

Purpose of the Study:

  • To summarize the current epidemiology of ZIKV.
  • To outline the clinical presentation and complications of ZIKV infection in children.
  • To review ZIKV diagnosis, management, treatment, and prevention strategies.

Main Methods:

  • Literature review of recent ZIKV research.
  • Synthesis of clinical findings and epidemiological data.
  • Analysis of current diagnostic and management guidelines.

Main Results:

  • ZIKV poses a significant threat as a cause of congenital infection.
  • Clinical manifestations in children range from acute illness to severe congenital complications.
  • Evolving understanding necessitates updated clinical knowledge for pediatricians.

Conclusions:

  • Pediatricians require up-to-date knowledge on ZIKV for optimal patient care.
  • Changes in screening guidelines emphasize the need for comprehensive clinical understanding.
  • Effective management and prevention rely on continuous learning in ZIKV research.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
324
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
337